AIDS 2022: The latest on long-acting HIV prevention and treatment
Elri Voigt summarises some of the latest developments on long-acting therapies for HIV presented at the 2022 International AIDS conference.
Opinion: World has reached another turning point in the fight against HIV
The world stands at an inflection point once more in the war against HIV. For those of us working in the field in South Africa, especially, it feels eerily like the battle that was fought 25 years ago, writes Dr Liesl Page-Shipp.
HIV prevention ring approved, but next steps unclear
The South African Health Products Regulatory Authority recently approved the use of the monthly dapivirine vaginal ring for women 18 years and older to reduce the risk of HIV infection. Thabo Molelekwa looks at the evidence for the ring’s efficacy and asks what plans there are for making it available to women in South Africa.
Prioritise HIV prevention injection, activists say
An HIV prevention injection taken every two months was recently approved in the United States. Several HIV activists interviewed by Thabo Molelekwa say that access to the injection should be prioritised in South Africa and that we need to do a better job in rolling out the injection than we did with the rollout of prevention pills.
